Literature DB >> 11832861

[Hereditary non polyposis colorectal cancer (HNPCC). A clinical and genetic entity].

L Bertolaccini1, G Olivero.   

Abstract

The first description of hereditary non polyposis colorectal cancer goes back to Warthin's study in 1895. In 1966 two families with autosomal dominant predisposition to colon and endometrial cancer were found. This condition was defined initially as familial neoplasm syndrome, then Lynch syndrome, and at last hereditary non polyposis colorectal cancer (HNPCC). HNPCC is classically subdivided into Lynch syndrome I (characterized by predisposition to colorectal cancer with early age of onset, to cancer of the proximal colon, and excess of synchronous and metachronous cancer), and Lynch syndrome II (characterized by similar colic phenotype with augmented risk of extracolonic neoplasm). If all clinical characteristics are present, it is possible to suspect HNPCC: however, diagnosis is difficult. Histological and genetic features of colon cancer confirm the diagnosis of HNPCC. Surgical therapy of colic neoplasm is total colectomy. A careful screening of HNPCC family members is one of the cardinal point in prevention. Follow-up of these surgical patients is the same as for sporadic neoplasms.

Entities:  

Mesh:

Year:  2002        PMID: 11832861

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  2 in total

1.  Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer.

Authors:  San-Jun Cai; Ye Xu; Guo-Xiang Cai; Peng Lian; Zu-Qing Guan; Shan-Jing Mo; Meng-Hong Sun; Qi Cai; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

2.  Colorectal cancer in cases of multiple primary cancers: Clinical features of 59 cases and point mutation analyses.

Authors:  Anshan Wu; Siqi He; Jingjing Li; Ling Liu; Chunlan Liu; Qi Wang; Xiaowei Peng; Jianda Zhou; Pei-Guo Cao; Ke Cao
Journal:  Oncol Lett       Date:  2017-04-26       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.